1. Home
  2. CNDT vs CRDL Comparison

CNDT vs CRDL Comparison

Compare CNDT & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$0.87

Market Cap

234.2M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

SELL

Current Price

$0.85

Market Cap

123.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CNDT
CRDL
Founded
2016
2017
Country
United States
Canada
Employees
51000
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.2M
123.9M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CNDT
CRDL
Price
$0.87
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
$5.00
★ $8.41
AVG Volume (30 Days)
★ 1.3M
519.3K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,042,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.95
$0.87
52 Week High
$2.13
$2.34

Technical Indicators

Market Signals
Indicator
CNDT
CRDL
Relative Strength Index (RSI) 22.99 24.51
Support Level N/A N/A
Resistance Level $1.71 $1.09
Average True Range (ATR) 0.11 0.07
MACD -0.05 0.00
Stochastic Oscillator 13.51 7.97

Price Performance

Historical Comparison
CNDT
CRDL

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: